可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Cannon RO , Schenke WH, Quyyumi A, et al. Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina[J]. Circulation, 1991, 83 (5 Suppl) : III77-III81.
[2] Cannon RO 3rd, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X[J]. Circulation, 1992,85(3):883-892.
[3] Luscher TF,Wenzel RR. Endothelin and endothelin antagonists pharmacology and clinical implications[J]. Agents Actions Suppl,1995,45:237-253.
[4] Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology[J]. Pharmacol Rev, 1991,43(2):109-142.
[5] Treasure GB, Klein L, Weinteraub WS, et al. Beneficial effect of cholesterollowering therapy on the coronary endothelium in patients with coronary artery disease[J]. N Engl J Med, 1995, 332(8): 481-487.
[6] 吴宁. 运动负荷试验[M]//陈敏章. 中华内科学. 北京:人民卫生出版社, 1999:1789
[7] Egashira K, Inou T, Hirooka Y,et al. Evidence of impaired endotheliumdependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms[J]. N Engl J Med, 1993,328(23):1659-1664.
[8] 刘宇宏,曾秋棠,毛晓波,等.氟伐他汀防治缺血性心脏病心衰及其抗氧化应激作用的实验研究[J]. 心脏杂志,2005,17(1):21-24,28.
[9] 张奇, 沈卫峰, 张建盛, 等. 卡维地洛与地尔硫卓对X 综合征伴冠状动脉血流储备异常患者疗效的对比研究[J]. 中华心血管病杂志, 2002, 30 (10):590-592.
[10]高展,高润霖,陈纪林,等.心脏X综合征患者长期随访研究[J].中华心血管病杂志,2004,32(6):483-485.